Holmlund Jon T - Sep 1, 2021 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
Chief Medical Officer
Signature
/s/ Christopher Degnan, Attorney-in-Fact for Jon T. Holmlund
Stock symbol
GRTX
Transactions as of
Sep 1, 2021
Transactions value $
-$288,451
Form type
4
Date filed
9/3/2021, 04:31 PM
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRTX Common Stock Options Exercise $116K +47.8K $2.43* 47.8K Sep 1, 2021 Direct
transaction GRTX Common Stock Sale -$404K -47.8K -100% $8.47* 0 Sep 1, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTX Stock Option Options Exercise $0 -47.8K -43.85% $0.00 61.1K Sep 1, 2021 Common Stock 47.8K $2.43 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2019.
F2 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.11 to $9.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The option has fully vested and is currently exercisable.